Figure 5.
Figure 5. The interaction of soluble Glu-Pg with αMβ2-expressing cells and the recombinant αMI-domain. (A) The αMβ2-expressing HEK 293 cells (106) were incubated with mAb 44a (40 μg/mL), mAb IB4 (30 μg/mL), or tranexamic acid (5 mM) in HBSS containing 0.1% BSA and 2 mM MnCl2 for 20 minutes at 22° C. Pg (10 μg/mL, 5 × 105 cpm/mL) was added, and the incubation was continued for another 20 minutes. Cell suspensions (50 μL) were layered over 300 μL of 20% sucrose in HBSS-BSA followed by centrifugation at 12 400g for 3 minutes. Radioactivity was measured as described in “Materials and methods.” (B) Binding of the radiolabeled Glu-Pg to immobilized αMI-domain.125I-Glu-Pg (20 μg/mL) was pretreated with P2 (100 μM), ϵ-ACA (50 mM), or tranexamic acid (5 mM) for 20 minutes at 22° C before being added to microtiter wells coated with αMI-domain (5 μg/mL) in the GST-free form and postcoated with 0.4% PVA. Binding of125I-Glu-Pg to the αMI-domain was quantitated. (C) Equilibrium analysis of the interaction of the αMI-domain with Pg. (i) Representative profiles of the SPR responses (RU) for Glu-Pg concentrations ranging from 0.1 μMto11 μM binding to the αMI-domain coupled to the chip surface. Pg was inactivated by incubating with diisopropylfluorophosphate. RU indicates response units. (ii) Saturable binding curve and (inset) Scatchard plot. Req indicates the response at equilibrium; C, the Glu-Pg concentration.

The interaction of soluble Glu-Pg with αMβ2-expressing cells and the recombinant αMI-domain. (A) The αMβ2-expressing HEK 293 cells (106) were incubated with mAb 44a (40 μg/mL), mAb IB4 (30 μg/mL), or tranexamic acid (5 mM) in HBSS containing 0.1% BSA and 2 mM MnCl2 for 20 minutes at 22° C. Pg (10 μg/mL, 5 × 105 cpm/mL) was added, and the incubation was continued for another 20 minutes. Cell suspensions (50 μL) were layered over 300 μL of 20% sucrose in HBSS-BSA followed by centrifugation at 12 400g for 3 minutes. Radioactivity was measured as described in “Materials and methods.” (B) Binding of the radiolabeled Glu-Pg to immobilized αMI-domain.125I-Glu-Pg (20 μg/mL) was pretreated with P2 (100 μM), ϵ-ACA (50 mM), or tranexamic acid (5 mM) for 20 minutes at 22° C before being added to microtiter wells coated with αMI-domain (5 μg/mL) in the GST-free form and postcoated with 0.4% PVA. Binding of125I-Glu-Pg to the αMI-domain was quantitated. (C) Equilibrium analysis of the interaction of the αMI-domain with Pg. (i) Representative profiles of the SPR responses (RU) for Glu-Pg concentrations ranging from 0.1 μMto11 μM binding to the αMI-domain coupled to the chip surface. Pg was inactivated by incubating with diisopropylfluorophosphate. RU indicates response units. (ii) Saturable binding curve and (inset) Scatchard plot. Req indicates the response at equilibrium; C, the Glu-Pg concentration.

Close Modal

or Create an Account

Close Modal
Close Modal